Insider · CIK 0001239746

GERAGHTY JAMES A

Reports to the SEC for 8 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001239746

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2026-06-09	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2025-06-26	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2025-06-03	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-12-12	PVLAPALVELLA THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−1 sh	$0.01	−$0.01	0
2024-08-07	PVLAPALVELLA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+1 sh	$1.00	+$1	1
2024-06-17	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-06-05	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-01-24	Orchard Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−44.4K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−46K sh	—	—	0
2024-01-24	Orchard Therapeutics plcStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−105K sh	—	—	0
2023-06-27	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-21	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2023-06-14	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+105K sh	—	—	105,000
2023-06-06	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2022-06-27	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19K sh	—	—	19,000
2022-06-23	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-06-22	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2022-06-07	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+46K sh	—	—	46,000
2022-06-06	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2021-06-28	FULCFulcrum Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$9.16	+$91.6K	90,714
2021-06-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2021-06-16	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-06-09	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-08	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2021-06-03	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-04-01	Aceragen, Inc.A Award	Director	AAward	+14.8K sh	$1.32	+$19.5K	119,543
2021-01-04	Aceragen, Inc.A Award	Director	AAward	+4,851 sh	$4.02	+$19.5K	104,770
2020-10-01	Aceragen, Inc.A Award	Director	AAward	+8,666 sh	$2.25	+$19.5K	99,919
2020-07-01	Aceragen, Inc.A Award	Director	AAward	+10.9K sh	$1.79	+$19.5K	91,253
2020-06-23	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2020-06-17	Orchard Therapeutics plcStock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2020-06-11	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,285 sh	—	—	9,285
2020-06-04	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-05-12	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2020-04-01	Aceragen, Inc.A Award	Director	AAward	+14.9K sh	$1.28	+$19.1K	80,359
2020-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2019-07-18	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,285 sh	—	—	9,285
2019-06-13	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-06-04	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2019-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-09-10	VYGRVoyager Therapeutics, Inc.P Purchase	Director	PPurchase	+3,000 sh	$19.39	+$58.2K	76,588
2018-08-17	VYGRVoyager Therapeutics, Inc.P Purchase	Director	PPurchase	+3,000 sh	$18.31	+$54.9K	73,588
2018-08-14	JUNIPER PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2018-08-14	JUNIPER PHARMACEUTICALS INCEmployee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−70K sh	—	—	0
2018-08-14	JUNIPER PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−80.7K sh	$11.50	−$929K	0
2018-08-07	Aceragen, Inc.P Purchase	Director	PPurchase	+10K sh	$5.58	+$55.8K	65,433
2018-07-02	Aceragen, Inc.A Award	Director	AAward	+8,096 sh	$1.32	+$10.7K	443,465
2018-06-20	Aceragen, Inc.Stock OptionsA Award	Director	AAward	+63K sh	$1.53	+$96.4K	63,000
2018-06-14	VYGRVoyager Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jul 24
GERAGHTY JAMES A0001193125-26-294690
SEC(opens sec.gov)
Jun 114
GERAGHTY JAMES A0001104659-26-072921
SEC(opens sec.gov)
Jun 304
GERAGHTY JAMES A0000950170-25-091584
SEC(opens sec.gov)
Jun 44
GERAGHTY JAMES A0001104659-25-056560
SEC(opens sec.gov)
Dec 124
GERAGHTY JAMES A0001437749-24-037353
SEC(opens sec.gov)
Oct 284
GERAGHTY JAMES A0001437749-24-032319
SEC(opens sec.gov)
Jun 184
GERAGHTY JAMES A0000950170-24-074885
SEC(opens sec.gov)
Jun 74
GERAGHTY JAMES A0001104659-24-069656
SEC(opens sec.gov)
Jan 244
GERAGHTY JAMES A0000950170-24-007087
SEC(opens sec.gov)
Jun 294
GERAGHTY JAMES A0000950170-23-030765
SEC(opens sec.gov)
Jun 234
GERAGHTY JAMES A0001437749-23-018283
SEC(opens sec.gov)
Jun 164
GERAGHTY JAMES A0001209191-23-037909
SEC(opens sec.gov)
Jun 74
GERAGHTY JAMES A0001104659-23-068922
SEC(opens sec.gov)
Jun 294
GERAGHTY JAMES A0000899243-22-024524
SEC(opens sec.gov)
Jun 274
GERAGHTY JAMES A0001415889-22-006940
SEC(opens sec.gov)
Jun 244
GERAGHTY JAMES A0001583648-22-000052
SEC(opens sec.gov)
Jun 84
GERAGHTY JAMES A0001209191-22-035009
SEC(opens sec.gov)
Jun 84
GERAGHTY JAMES A0001104659-22-069349
SEC(opens sec.gov)

Companies

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139